07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BBLD<br />

8082<br />

CFRC<br />

89653<br />

infections. Many Bacterioides produce beta-lactamase and are resistant to penicillins and cephalosporins.<br />

Imipenem, metronidazole, and clindamycin are effective agents although resistance to clindamycin is<br />

increasing.<br />

Useful For: Diagnosing anaerobic bacterial infections<br />

Interpretation: Isolation of anaerobes in significant numbers from well collected specimens<br />

including blood, other normally sterile body fluids, or closed collections of purulent fluid indicates<br />

infection with that (those) organism(s).<br />

Reference Values:<br />

Not applicable<br />

Clinical References: Finegold SM, George WL: Anaerobic Infections in Humans. San Diego, CA,<br />

Academic Press, 1989<br />

Bacterial Culture, Blood<br />

Clinical Information: When bacteria multiply at a rate that exceeds removal by phagocytes,<br />

bacteremia results. The clinical pattern of bacteremia may be transient, intermittent, or continuous.<br />

Transient bacteremia often occurs after manipulative procedures (dental procedures, cystoscopy) or<br />

surgery in contaminated areas of the body. Undrained abscesses (intraabdominal, pelvic, hepatic) may<br />

result in intermittent bacteremia. A hallmark feature of subacute bacterial endocarditis is a continuous<br />

bacteremia. The sources of bacteremia are the genitourinary tract (25%), the respiratory tract (20%),<br />

abscesses (10%), surgical wounds (5%), the biliary tract (5%), other known sites (10%), and unknown<br />

sites (25%).<br />

Reference Values:<br />

No growth<br />

Identification of all organisms<br />

Clinical References: Mandell GL, Bennett JE, Dolin R: In Mandell, Douglas, and Bennett's<br />

Principles and Practice of Infectious Diseases. Sixth edition. New York, NY, Churchill Livingstone,<br />

2005, pp. 906-926.<br />

Bacterial Culture, Cystic Fibrosis, Respiratory<br />

Clinical Information: Life expectancy of patients with cystic fibrosis (CF) has increased steadily<br />

over the past 50 years, in large part due to improvements in the management of lung disease in this<br />

patient population. Still, chronic lung infection is responsible for 75% to 85% of deaths in patients with<br />

CF. Appropriate treatment for the causative organism can reduce morbidity and mortality. The number<br />

of microbial species associated with CF lung disease is relatively limited. These include Pseudomonas<br />

aeruginosa (mucoid and nonmucoid), Staphylococcus aureus, Burkholderia cepacia complex,<br />

Stenotrophomonas maltophilia, other nonfermenting gram-negative rods, Haemophilus influenzae, and<br />

Streptococcus pneumoniae. Nontuberculous mycobacteria and Aspergillus species may also play a role<br />

in CF lung disease, in addition to common respiratory viruses. This culture, which is specifically<br />

designed for CF patients, utilizes conventional and additional selective media (compared to non-CF<br />

respiratory cultures) to isolate bacteria commonly associated with pulmonary disease in CF patients. In<br />

selected centers, lung transplantation is performed on CF patients. This test is appropriate for lung<br />

transplant patients with underlying CF because they can continue to harbor the same types of organisms<br />

as they did pretransplantation. CF patients may be colonized or chronically infected by these organisms<br />

over a long period of time.<br />

Useful For: Detection of aerobic bacterial pathogens from cystic fibrosis patient specimens<br />

Interpretation: A negative test result is no growth of bacteria or growth of only usual flora. A<br />

negative result does not rule out all causes of infectious lung disease (see "Cautions"). For positive test<br />

results, pathogenic bacteria are identified. Because cystic fibrosis (CF) patients may be colonized or<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 219

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!